[Treatment by intravenous administration of novocaine of patients with obliterating endarteritis and atherosclerosis].
D061605:Administration, Intravenous; D001161:Arteriosclerosis; D050197:Atherosclerosis; D004692:Endarteritis; D006801:Humans; D011343:Procaine; D013919:Thromboangiitis Obliterans
D011343:Procaine
ARTERIOSCLEROSIS; ENDARTERITIS; PROCAINE; THROMBOANGIITIS OBLITERANS